Rewiring Biological Time and Aging with Epigenome Editing
Charles A. Gersbach, PhD
The bright, new future of therapeutic epigenome editing is already on our doorstep
epigenetics
AlidaBio Launches EpiPlex™ Platform to Advance Epitranscriptomic Research
AlidaBio
EpiPlex is first platform to offer multitarget, quantitative analysis of RNA modifications to provide comprehensive detection and characterization of the epitranscriptome
Potential Epigenetic Biomarker Found for Preeclampsia in Pregnancy
Washington State University
New study offers hope that a simple test can be developed to identify preeclampsia earlier in pregnancy
Researchers Discover Cancers of Epigenetic Origin without DNA Mutation
French National Centre for Scientific Research
Scientists demonstrate that genetic mutations are not essential for the development of cancer
New Clues on What Causes Gestational Diabetes
Harvard Pilgrim Health Care Institute
New study suggests the placenta is a key factor in the development of gestational diabetes
Elevating Cancer Diagnostics and Treatment Using Epigenetics
Moshe Szyf, PhD
Integrating epigenetic insights into cancer research could help deliver personalized, high-quality, and cost-effective patient care
New Study Unveils a Potential Pan-Cancer Biomarker
Impact Journals, LLC
Bioinformatics and epigenetic analyses link XRCC1 to some 10 cancer types
New Blood Test Detects Advanced Prostate Cancer Subtypes
Swathi Kodaikal, MSc
Liquid biopsy method uses methylated cell-free DNA to identify, classify, and quantify tumor burden and type
Transposable Elements Causing Rare MSL3 Syndrome Identified
Queen Mary University of London
Mutations in the MSL3 gene can lead to a global delay in the development of multiple organs in children
Can Chromosomal Instability Drive Epigenetic Alterations in Cancer Cells?
Memorial Sloan Kettering Cancer Center
Sequestration of chromosomes into micronuclei disrupts the organization of chromatin and triggers epigenetic dysregulation